Prescribers Should Restrict the Use of Non-FDA-Approved Compounded Bioidentical Hormones, Except for Specific Medical Circumstances
The use of compounded bioidentical hormone therapies (cBHTs) — an increasingly preferred technique to reduce indicators of menopause and male...
